Allan Harrington is a Dermatologist in Glen Burnie, Maryland. Dr. Harrington is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, Bowen's Disease, and Head and Neck Squamous Cell Carcinoma (HNSCC).

Cheryl Lonergan is a Dermatologist in Glen Burnie, Maryland. Dr. Lonergan is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. Her top areas of expertise are Actinic Keratosis, Warts, Basal Cell Skin Cancer, and Plaque Psoriasis.

Marianne Dawn is a Dermatologist in Glen Burnie, Maryland. Dr. Dawn is rated as an Advanced provider by MediFind in the treatment of Basal Cell Skin Cancer. Her top areas of expertise are Syringoma, Sebaceous Adenoma, Syringocystadenoma Papilliferum, and Rosacea.

Richard Pfau is a Dermatologist in Millersville, Maryland. Dr. Pfau is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Basal Cell Skin Cancer, Actinic Keratosis, Acanthosis Nigricans, and Squamous Cell Skin Carcinoma.

Tina Nandi is a Dermatologist in Glen Burnie, Maryland. Dr. Nandi is rated as an Experienced provider by MediFind in the treatment of Basal Cell Skin Cancer. Her top areas of expertise are Pemphigus Vulgaris, Neurocutaneous Melanosis, Giant Congenital Nevus, and Giant Congenital Melanocytic Nevus.

Dr. Lipson is an internationally-recognized skin cancer and immunotherapy specialist at Johns Hopkins. He received his medical degree in 2005 from the Mount Sinai School of Medicine in New York City, where he graduated with distinction in research. He completed his internship and residency in Internal Medicine at The Johns Hopkins Hospital, and completed a Medical Oncology fellowship at the Johns Hopkins Kimmel Cancer Center. Dr. Lipson leads cutting edge clinical trials for patients with melanoma and other skin cancers. As a member of the Johns Hopkins Melanoma and Cancer Immunology Programs, he focuses on evaluating novel therapies for patients with high-risk or advanced disease. Dr. Lipson’s publications include the first reports of organ transplant recipients treated with immune checkpoint inhibitors for advanced cancer, and the first description of kidney retransplantation performed after immunotherapy–related organ rejection. Based on his published work, Dr. Lipson initiated a clinical trial testing a novel combination of immune-based therapies for kidney transplant recipients with advanced selected cancers. Results from this trial - the first of its kind - were reported in 2022 at an international oncology meeting. Dr. Lipson is a leader in the clinical development of relatlimab, an antibody blocking the LAG-3 immune checkpoint. He leads a phase 2 trial testing combination immune checkpoint inhibitor therapy—including anti-LAG-3—for patients with advanced basal cell carcinoma. In June 2021, Dr. Lipson presented findings from the first phase 3 study establishing the LAG-3 pathway as the third immune checkpoint pathway in history, after CTLA-4 and PD-1, for which blockade has clinical benefit. This trial supported the FDA's approval of a new therapy for patients with advanced melanoma. In addition to his research activities, Dr. Lipson is an educator in the field of cancer immunotherapy. Many of his lectures focus on the management of immune-mediated drug toxicities associated with novel cancer drugs. Dr. Lipson conducts regular clinical practices in Baltimore, Maryland and at Sibley Memorial Hospital in Washington, D.C. as part of the multidisciplinary Melanoma Program at Johns Hopkins. Dr. Lipson is rated as an Advanced provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Metastatic Uveal Melanoma, Squamous Cell Skin Carcinoma, and Pancreaticoduodenectomy.

Dr. Jihad Mohamad Alhariri is an assistant professor of dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include dermatology and medical dermatology. Dr. Alhariri received his undergraduate degree from the American University of Beirut. He earned his M.D. from the American University of Beirut and his M.P.H. from the Johns Hopkins University School of Public Health. He completed a residency in internal medicine at Good Samaritan Hospital of Maryland and a residency in dermatology at Johns Hopkins. Dr. Alhariri is rated as an Advanced provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Melanoma, Hidradenitis Suppurativa, Familial Atypical Multiple Mole Melanoma Syndrome, and Giant Congenital Melanocytic Nevus.

Dr. Janis Taube is a professor of dermatology and pathology at the Johns Hopkins University School of Medicine and a member of the Johns Hopkins Kimmel Cancer Center. Her area of clinical expertise is dermatopathology. Dr. Taube serves as the Director of the Division of Dermatopathology and as the Assistant Director of the Dermatoimmunology Laboratory at the School of Medicine. Dr. Taube received her undergraduate degree in engineering from Duke University. She earned her M.D. from Tulane University and her M.Sc. in molecular medicine from University College London. She completed her residency in pathology at Johns Hopkins where she also served as the chief resident, before undertaking a dermatopathology fellowship at Stanford University. In 2009, Dr. Taube returned to Johns Hopkins for her certification in the Melanoma Clinic. She is one of the lead scientific researchers in the Department of Dermatology at Johns Hopkins. She has written over 180 peer-reviewed publications, and her research has been cited over 70,000 times. In addition to running her own research laboratory, she serves as the co-Director of the Mark Foundation Center for Advanced Genomics and Imaging and also as the co-Director of the Tumor Microenvironment Core Laboratory for the Bloomberg~Kimmel Institute for Cancer Immunotherapy. Dr. Taube is rated as an Advanced provider by MediFind in the treatment of Basal Cell Skin Cancer. Her top areas of expertise are Melanoma, Merkel Cell Carcinoma, Basal Cell Skin Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), and Pancreaticoduodenectomy.

George Grace is a Plastic Surgeon in Baltimore, Maryland. Dr. Grace is rated as an Advanced provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Basal Cell Skin Cancer, Breast Enlargement In Males, Squamous Cell Skin Carcinoma, and Keloids.

Sammy Kang is a Dermatologist in Millersville, Maryland. Dr. Kang is rated as an Advanced provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Universal Acquired Melanosis, Liver Spots, Sebaceous Adenoma, and Syringoma.

Margaret Moresi is a Dermatologist in Millersville, Maryland. Dr. Moresi has been practicing medicine for over 37 years and is rated as an Advanced provider by MediFind in the treatment of Basal Cell Skin Cancer. Her top areas of expertise are Actinic Keratosis, Basal Cell Skin Cancer, Bowen's Disease, and Griscelli Syndrome.

Stephanie Clements is a Dermatologist in Millersville, Maryland. Dr. Clements has been practicing medicine for over 10 years and is rated as an Advanced provider by MediFind in the treatment of Basal Cell Skin Cancer. Her top areas of expertise are Giant Congenital Nevus, Basal Cell Skin Cancer, Melanoma, and Giant Congenital Melanocytic Nevus.

Dr. Heather Pacheco is a graduate of the University of Miami School of Medicine. She completed her Internal Medicine Internship at The University of Miami/Jackson Health System. She went on to complete her dermatology residency at the University of Miami Department of Dermatology and Cutaneous Surgery. She was awarded the department’s prestigious medical student teaching award as a resident. Dr. Pacheco is a fellow of the American Academy of Dermatology. Dr. Pacheco has practiced adult, pediatric and cosmetic dermatology in the Annapolis area since 2004. When not caring for her patients she enjoys spending time with family and friends, reading, traveling and attending classes at Pure Barre. Dr. Pacheco is rated as an Experienced provider by MediFind in the treatment of Basal Cell Skin Cancer. Her top areas of expertise are Seborrheic Keratosis, Warts, Actinic Keratosis, and Grover's Disease.

Jennifer Powers is a Plastic Surgeon and a Dermatologist in Baltimore, Maryland. Dr. Powers is rated as an Advanced provider by MediFind in the treatment of Basal Cell Skin Cancer. Her top areas of expertise are Basal Cell Skin Cancer, Actinic Keratosis, Pityriasis Rubra Pilaris, and Squamous Cell Skin Carcinoma.

Jun Kang is a Dermatologist in Baltimore, Maryland. Dr. Kang is rated as an Experienced provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Dermatomyositis, Cutaneous Lupus Erythematosus (CLE), Discoid Lupus Erythematosus (DLE), and Localized Scleroderma.

Inbal Sander is a Dermatologist in Baltimore, Maryland. Dr. Sander is rated as an Experienced provider by MediFind in the treatment of Basal Cell Skin Cancer. Her top areas of expertise are Warts, Actinic Keratosis, Seborrheic Keratosis, and Hemangioma.

Dr. Grant Anhalt is a professor of dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include autoimmune skin diseases and dermatoimmunology. Dr. Anhalt serves as the director of the Dermatoimmunology Laboratory at the Johns Hopkins School of Medicine. He received his undergraduate degree and his M.D. from the University of Manitoba. He completed a residency in internal medicine at the Health Sciences Center in Winnipeg, Canada and a residency in dermatology at the University of Michigan. He performed a fellowship in immunodermatology at the University of Michigan Medical Center. Dr. Anhalt joined the Johns Hopkins faculty in 1982. He was interim chair of the Department of Dermatology from 1996 to 2001. His research interests include autoimmunity, bullous skin diseases and pemphigus and pemphigoid. Dr. Anhalt serves on the medical advisory board for the International Pemphigus & Pemphigoid Foundation. He has been recognized as a top doctor in the Washington Post Magazine, Baltimore Magazine and Castle Connolly Guide. He is a member of several professional organizations, including the American Academy of Dermatology, American Dermatologic Association and American Society for Clinical Investigation. CV http://www.hopkinsmedicine.org/dermatology/our_experts/CV/Anhalt_CV_2014.docx. Dr. Anhalt is rated as an Experienced provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Pemphigus Vulgaris, Pemphigus, Pemphigus Foliaceus, and Bullous Pemphigoid.

"Daniel J. Lewis, M.D. is a dual fellowship-trained Mohs and reconstructive surgeon and Assistant Professor of Dermatology at Johns Hopkins University School of Medicine. He leads the Mohs surgery unit at the Johns Hopkins Outpatient Center (JHOC), the hospital's flagship facility in downtown Baltimore. He is also heavily involved in education as the director of the JHOC resident surgery clinic and as core faculty for the Micrographic Surgery and Dermatologic Oncology fellowship. Dr. Lewis earned a B.A. in Biology from the University of Pennsylvania, earned his M.D. at Baylor College of Medicine while completing a research fellowship at The University of Texas MD Anderson Cancer Center, and completed his internship at Memorial Sloan Kettering Cancer Center. He then returned to Penn for dermatology residency, serving as chief resident at the country's No. 1-ranked dermatology program by Doximity. At Penn, he pursued further specialization with two year-long post-doctoral fellowships in cutaneous oncology and Mohs micrographic surgery. During his Mohs fellowship at Penn, Dr. Lewis worked at the largest academic Mohs surgery center in the country alongside leaders in the field and pioneers in the use of Mohs surgery with immunohistochemistry, complex reconstruction, high-risk tumors, and tumors on specialty sites. Dr. Lewis has authored over 90 peer-reviewed manuscripts in high-impact journals such as Journal of the American Academy of Dermatology, JAMA Dermatology, and Journal of Investigative Dermatology. He has also served on the Editorial Board of the International Journal of Dermatology and has authored multiple textbook chapters as well as two editions of the book Practical Ways to Improve Patient Adherence, named the winner of the 2022 ""Best Overall"" Dermie Award by Dermasphere. Dr. Lewis is an aspiring leader in cutaneous oncology and was named Post-Doctoral Trainee of the Year in 2022 by ADEN, winner of the 2022 ASDS Young Investigators Writing Competition, and a Rising Scholar by the Dermatology Foundation in 2023. He is a member of the Alpha Omega Alpha Honor Medical Society. He is passionate about Mohs micrographic surgery and has clinical interests in advanced facial reconstruction, Mohs surgery with immunohistochemistry, facial anatomy, Merkel cell carcinoma, melanoma, and patient adherence.". Dr. Lewis is rated as an Experienced provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Mycosis Fungoides, and Sezary Syndrome.

Dr. Damon S. Cooney is an associate professor of plastic and reconstructive surgery at the Johns Hopkins University School of Medicine. Dr. Cooney performs all types of general plastic surgery but specializes in microvascular reconstruction (free flaps). A particular focus of his clinical practice is improving the functional and aesthetic results of head and neck reconstruction. He completed additional fellowship training at the University of Pittsburgh to become an expert in microsurgical techniques for reconstructing the extremities, trunk, breast, and head and neck following traumatic and/or oncological defects. Dr. Cooney earned a Ph.D. from Ohio State University Department of Molecular, Cellular and Development Biology. Dr. Cooney’s clinical and basic research focus is composite tissue allotransplantation (CTA). He is a member of the Composite Tissue Allotransplantation team at Johns Hopkins and helps conduct human hand and face transplantation trials. His laboratory work includes engineering human tissues for reconstructive purposes, nerve regeneration, microsurgical education and inducing tolerance in order to reduce or eliminate the need for systemic immunosuppression in transplantation patients. Dr. Cooney has published numerous peer-reviewed articles and book chapters in addition to being a reviewer for plastic surgery journals. He is a founding member of the American Society for Reconstructive Transplantation. Dr. Cooney is rated as an Experienced provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Keloids, Hidradenitis Suppurativa, Squamous Cell Skin Carcinoma, Osteotomy, and Abdominal Wall Surgery.

Daniel Synkowski is a Dermatologist in Baltimore, Maryland. Dr. Synkowski is rated as an Experienced provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Hidradenitis Suppurativa, Melanoma, Actinic Keratosis, and Warts.